Cargando…
Promoter hypermethylation of MGMT gene may contribute to the pathogenesis of gastric cancer: A PRISMA-compliant meta-analysis
BECKGROUND: The association of MGMT (O(6)-methyguanine deoxyribonucleic acid methyltransferase) promoter hypermethylation with gastric cancer (GC) risk has been studied extensively, but the results remained unclear. Here, we performed a meta-analysis to evaluate whether promoter hypermethylation of...
Autores principales: | Zhang, Zongxin, Xin, Shaojun, Gao, Min, Cai, Yunxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413244/ https://www.ncbi.nlm.nih.gov/pubmed/28445279 http://dx.doi.org/10.1097/MD.0000000000006708 |
Ejemplares similares
-
Can S-1 replace fluorouracil for advanced gastric cancer? A PRISMA-compliant systematic review and meta-analysis
por: Chen, Xiao-Dong, et al.
Publicado: (2016) -
Association between the polymorphisms in XPG gene and gastric cancer susceptibility in Chinese populations: A PRISMA-compliant meta-analysis
por: Xia, Jun, et al.
Publicado: (2017) -
Which are the best Chinese herbal injections combined with XELOX regimen for gastric cancer?: A PRISMA-compliant network meta-analysis
por: Zhang, Dan, et al.
Publicado: (2018) -
Menopausal status and the risk of lung cancer in women: A PRISMA-compliant meta-analysis
por: Min, Lingfeng, et al.
Publicado: (2017) -
The risks of hematological toxicities of nivolumab in cancer patients: A PRISMA-compliant meta-analysis
por: Shi, Zuolin, et al.
Publicado: (2022)